Test Price
1,400 AED✅ Home Collection Available
Cystic Fibrosis (CFTR‑Del F508) Mutation Screening, Prenatal in UAE | 1400 AED
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO‑Accredited Sanger Sequencing
- Premium Logistics: Hospital Extraction Only – Sample collection is conducted strictly within an accredited hospital facility; mobile home phlebotomy is disabled for safety.
- Clinical Guidance: Telephonic Post‑Test Clinical Correlation by DHA‑Licensed Genetic Counsellor
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731
Test Overview & Methodology
This prenatal screening test identifies the most common cystic fibrosis‑causing mutation — CFTR‑Del F508 (p.Phe508del) — in fetal cells obtained from amniotic fluid, chorionic villi, or umbilical cord blood. Results are delivered within 7–8 days at a cost of 1400 AED.
| Feature | Our Test | Closest Alternative (NGS Panel) |
|---|---|---|
| Precision | Single‑mutation targeted Sanger Sequencing, 99.9% analytical sensitivity | Multi‑gene NGS with ~98% sensitivity for full gene sequencing |
| Turnaround | 7–8 days | 10–14 days |
| UAE Regulatory Acceptance | DHA/MOHAP Standard Nomenclature, ISO 9001:2015 | May require additional validation for prenatal use |
Physician Insight & Safety Protocols
“A positive CFTR‑Del F508 result in a prenatal sample is not a final diagnosis but a critical step that must be correlated with family history, ultrasound findings, and confirmatory testing. I urge parents to discuss the implications with a clinical geneticist before making any decisions.” – Lina Osama Zaki Quteineh, Consultant Medical Genetics (DHA: 9294403)
Medication Advisory
Medication Warning: Do not discontinue any prescribed medication or supplement without explicit instruction from your supervising physician.
Exclusion Criteria & Emergency Red Flags
- A doctor’s prescription is mandatory, except for surgical clearance, pregnancy‑related evaluations, or international travel health certificates.
- Invasive prenatal sampling (amniocentesis/CVS) is performed only under obstetric supervision; patients with active vaginal bleeding, premature rupture of membranes, or untreated uterine infection are excluded.
- Seek Emergency Care Immediately If: You experience severe abdominal pain, heavy vaginal bleeding, fluid leakage, or fever >38°C after the procedure.
Patient FAQ & Clinical Guidance
1. What is the purpose of CFTR‑Del F508 screening during pregnancy?
This prenatal test specifically detects the most common cystic fibrosis mutation (ΔF508) in fetal DNA, allowing early risk assessment, pregnancy management, and preparation for neonatal care.
2. Is the procedure safe for my baby and me?
Obstetricians perform the sample collection under ultrasound guidance using sterile single‑use equipment, keeping procedural risk below 0.3% when all exclusion criteria are met.
3. How soon can I get results, and will a doctor explain them?
You receive a comprehensive report within 7–8 working days, followed by a complimentary telephonic consultation with a DHA‑licensed genetic counsellor to interpret findings and next steps.
UAE Regulatory & Data Privacy Adherence
Compliance Framework
- Data Protection: Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL)
- Health Information Technology: Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields
- Medical Liability & Patient Consent: Federal Decree‑Law No. 4 of 2016 on Medical Liability
- Quality Certification: ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139)
Clinical & Logistical Metadata
| Test Name | Cystic Fibrosis (CFTR‑Del F508) Mutation Screening, Prenatal |
| Price (AED) | 1,400 AED |
| Turnaround Time | 7–8 days |
| Sample Type / Matrix | Amniotic fluid, chorionic villi, or umbilical cord blood (Hospital Extraction Only – Sample collection is conducted strictly within an accredited hospital facility; mobile home phlebotomy is disabled for safety.) |
| Methodology Used | Sanger Sequencing (Targeted Mutation Analysis) |
| ICD-10-CM Code | E84.9 |
| LOINC Code | 21636-6 |
| DHA Facility License & Laboratory Address Invariants | License No: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians